S

Sprint Bioscience

44 employees

Sprint Bioscience AB offers a modular gene-to-lead drug discovery platform for fragment-based drug discovery, including protein expression

Basic info

Industry

pharmaceutical manufacturing

Sectors

Tumor Metabolism
Biotechnology
oncology therapeutics targeting cancer metabolism
Fragment Based Drug Discovery
Oncology
Pharmaceutical
Drug Development
Biopharma
Drug Discovery
Cancer

Date founded

2009

Funding rounds raised

S

Sprint Bioscience raised undisclosed on October 19, 2012

Investors: Almi Invest

S

Sprint Bioscience raised undisclosed on November 25, 2010

Investors: Almi Invest

FAQ